Reeve Waud founded Waud Capital Partners in Chicago in 1993 and has spent three decades building and adapting the firm as markets shifted. Most PE founders sell, retire, or stagnate. Reeve Waud adapted. The official announcement of Chief AI and Data Officer appointment signals another chapter of evolution and forward thinking.
The numbers reflect that consistency. Over 30 years, Waud Capital has deployed approximately $3.2 billion in capital. The firm has completed more than 500 investments, spanning both platform acquisitions and follow-on expansions. The firm’s focus has remained consistent: healthcare and software. Those are not sectors that became trendy overnight. They are sectors that Reeve Waud identified early, committed to understanding deeply, and continued backing through multiple market cycles. Responsible investing framework shows how the firm integrates values into capital allocation decisions.
Typical deal sizes range from $75 million to $200 million in equity, a range that has stayed relatively stable across the decades. That consistency is revealing. Waud Capital has not been chasing bigger and bigger deals. It has stayed in a zone where the firm can add value through hands-on operational involvement rather than financial engineering and leverage. Partner promotions announcement underscore the firm’s commitment to developing internal talent capable of executing the investment thesis.
The Early Years: Sector Specialization as Moat
In 1993, healthcare was not an obvious choice. Venture capitalists funded software; leveraged buyout shops stripped industrial assets. Reeve Waud’s choice reflected a bet on structural trends: aging demographics, rising costs, regulatory pressure, and supply chain fragmentation. Specialization in one or two sectors was unusual then, but allowed him to develop relationships, understand dynamics, and spot opportunities generalists missed.
This thesis played out across three decades. Healthcare consolidation accelerated. Regulatory pressures mounted. Technology became more important to healthcare delivery. Software companies scaled from niche tools to critical infrastructure. The sectors Reeve Waud chose did not become irrelevant. They became foundational to the economy. Reeve Waud’s professional network reflects three decades of relationships in healthcare and software sectors.
That long-term patience is rare. Most PE founders assume their original thesis will work forever. Reeve Waud appears to have understood that while the sector thesis could remain constant, the way to succeed within those sectors would shift repeatedly. Each wave of change required adaptation.
The Evolution of Value Creation
Value creation methods shifted repeatedly. In the 1990s, it meant operational consolidation-buying fragmented clinics, unifying management, exiting at higher multiples. By the 2000s, healthcare regulatory complexity increased while SaaS models replaced perpetual software licensing. By the 2010s, digital transformation became central: healthcare providers needed analytics; software companies needed cloud architecture.
Through each shift, Reeve Waud maintained the firm’s core operating model: sector focus, hands-on operational support, and patience. The model absorbed new value creation drivers while remaining recognizable in its discipline. Waud Capital ownership stake analysis provides insight into how portfolio companies integrate with broader Waud Capital strategy.
Strategic Partnerships and Specialization Within Specialization
In July 2025, Waud Capital announced a partnership with Bill Mixon focused on medical devices and supply chain optimization, with more than $100 million in committed capital. This was a further narrowing of the healthcare thesis, reflecting recognition that supply chain complexity in medical devices was an underutilized value creation lever. Reeve Waud’s insider profile documents his substantial personal investment in healthcare outcomes.
This specialization-within-specialization allowed the firm to recruit deeper expertise in a specific area where it could add genuine value.
The AI Era and Maintaining Relevance
Now, in 2026, Reeve Waud has appointed Prithvi Raj as Chief AI and Data Officer-a position Waud Capital created to signal that the next phase of value creation will be algorithmic. This is not Reeve Waud abandoning his original thesis. It is Reeve Waud updating it. For thirty years, his edge was sector knowledge, operational discipline, and patience. Those advantages still exist. But they are now being augmented by data capability.
Portfolio companies in healthcare that can predict patient outcomes, optimize supply chains, or reduce administrative cost through machine learning will compound value faster than those that cannot. The appointment of Prithvi Raj, with his background at McKinsey, Microsoft, Zynga, SquareFoot, and Newmark, reflects Reeve Waud’s judgment about where healthcare and software PE must go next. It also reflects something else: the willingness to evolve. Most founders, at year 30, are on autopilot. Reeve Waud is still investing in new capabilities. He is still placing bets on what the industry will require. He is still adapting the firm to remain competitive. That is unusual. It is also, based on thirty years of results, the pattern that created value in the first place.
